http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150046708-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2014-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150046708-A |
| titleOfInvention | Use of the TC1(C8orf4) gene regulating hematopoietic progenitor cells and hematopoiesis |
| abstract | The present invention relates to hematopoietic progenitor cells and the use of the gene TC1 (C8orf4) which regulates hematopoiesis. The present invention provides a pharmaceutical composition for promoting hematopoiesis comprising TC1 (C8orf4) protein expression or activity inhibitor as an active ingredient. The present invention also relates to a method for producing a test compound, comprising the steps of: contacting a test substance with a cell comprising a TC1 ( C8orf4 ) gene or a TC1 (C8orf4) protein; Measuring the expression or activity level of TC1 (C8orf4) protein in the cell to which the test substance is contacted; And selecting a test substance in which the degree of expression or activity of the TC1 (C8orf4) protein is decreased as compared with a control sample. The TC1 (C8orf4) protein of the present invention is considered to be a useful target for the development of drugs for promoting hematopoiesis as an inhibitor of hematopoiesis. |
| priorityDate | 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 191.